Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
133.96
+0.14 (0.10%)
At close: Jul 14, 2026, 4:00 PM EDT
133.85
-0.11 (-0.08%)
After-hours: Jul 14, 2026, 7:34 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $10.04 billion as of July 14, 2026. Its market cap has increased by 296.52% in one year.
Market Cap
10.04B
Enterprise Value
8.79B
1-Year Change
296.52%
Ranking
Category
Stock Price
$133.96
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $10.04B, an increase of 1,141.22%. That is a compound annual growth rate of 131.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 10.04B | 97.09% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 11.43B |
| Bio-Techne | 11.11B |
| Krystal Biotech | 10.78B |
| Arrowhead Pharmaceuticals | 10.76B |
| Corcept Therapeutics | 9.86B |
| Nuvalent | 9.83B |
| Kymera Therapeutics | 9.82B |
| Ionis Pharmaceuticals | 9.63B |